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doi:10.1016/j.jtcvs.2003.11.0171574 The Journal of Thoracic and CardObjective: The definition of visceral pleural invasion in lung cancer TNM classifi-
cation of the International Union Against Cancer lacks detail. The purpose of this
study was to evaluate the significance of the extent of pleural involvement as a
prognostic factor and to propose a refined TNM classification on the basis of
visceral pleural invasion.
Methods: We reviewed 1653 consecutive patients with T1, T2, and T3 surgically
resected non–small cell lung cancer for their clinicopathologic characteristics and
prognoses. Visceral pleural invasion was classified by using the Japan Lung Cancer
Society criteria: p0, tumor with no pleural involvement beyond its elastic layer; p1,
tumor extension beyond the elastic layer but no exposure on the pleural surface; and
p2, tumor exposure on the pleural surface.
Results: The 5-year survivals for patients with p1 or p2 tumors of 3 cm or less were
identical and significantly worse than those for patients with p0 tumors of the same
size. Patients with p1 or p2 tumors of greater than 3 cm and patients with T3 cancers
had essentially identical survivals.
Conclusions: Visceral pleural invasion should be defined as tumor extension beyond
the elastic layer of the visceral pleura, regardless of its exposure on the pleural
surface. A tumor of 3 cm or less with visceral pleural invasion should remain
classified as a T2 tumor, as presently occurs in the International Union Against
Cancer staging system, and tumors of greater than 3 cm with visceral pleural
invasion should be upgraded to T3 status in the International Union Against Cancer
TNM classification.
Lung cancer pleural invasion was recognized as a poor prognosticfactor as early as 1958 by Brewer and colleagues.1 Visceral pleuralinvasion (VPI) was adopted as a specific description in the TNMclassification of the International Union Against Cancer (UICC)staging system in the mid-1970s2 and has remained unchanged untiltoday: a tumor of any size that invades the visceral pleura is classi-
fied as T2. Although a tumor of 3 cm or less is upgraded to T2, a tumor of greater
than 3 cm remains T2 in this system if a tumor has VPI.
The UICC TNM classification describes little on VPI definition. The Japan Lung
Cancer Society (JLCS) classifies VPI as follows: p0, tumor with no pleural involve-
ment beyond its elastic layer; p1, tumor that extends beyond the elastic layer of the
visceral pleura but is not exposed on the pleural surface; p2, tumor that is exposed
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tomic structures; and p3, tumor that involves adjacent ana-
tomic structures.3 The Society classifies a p2 tumor of any
size as T2 and a p1 tumor of 3 cm or less as T1. The UICC
TNM classification does not clarify whether VPI includes
p1. Given that p1 pleural involvement is interpreted as VPI
in the UICC classification, there appears to be an inconsis-
tency in the T1/T2 definition between the UICC and JLCS
TNM classifications. To the best of our knowledge, there
have been no studies reported on p1 pleural involvement as
a prognostic factor.
The purpose of this study was to evaluate the signifi-
cance of p1 pleural involvement as a prognostic factor and
to propose a refined TNM classification on the basis of VPI.
Patients and Methods
From February 1979 through March 2001, 1653 consecutive pa-
tients with T1, T2, or T3 non–small cell lung cancer underwent
pulmonary resection (segmentectomy or more) and systematic
mediastinal lymph node dissection at our institution, as described
previously.4 All these patients had curative resection, which was
defined as complete removal of ipsilateral hilar and mediastinal
lymph nodes together with the primary tumor. Patients who had
induction chemotherapy or radiotherapy and patients with evi-
dence of residual tumor at the surgical margin, malignant effusion,
satellite lesion, or distant metastasis verified intraoperatively or by
means of postoperative pathologic examination were excluded
TABLE 1. Patient characteristics
Characteristics p0
Age (y)
Mean  SD 64 10
Range 30-85
Sex (male/female) 662/393
Type of operation
Segmentectomy 21 (2)
Lobectomy 993 (94) 2
Pneumonectomy 41 (4)
Histology
Adenocarcinoma 679 (64) 1
Squamous cell carcinoma 311 (30)
Large cell carcinoma 36 (3)
Adenosquamous carcinoma 29 (3)
Size
3cm 624 (59) 1
3cm 431 (41) 1
Pathologic
n0 795 (75) 1
n1 134 (13)
n2 126 (12)
Total 1055
Numbers in parentheses are percentages. n0, No regional lymph node me
hilar lymph nodes, or both, and intrapulmonary nodes, including involve
mediastinal lymph nodes, subcarinal lymph nodes, or both.from this study. Patients were pathologically staged on the basis of
The Journal of Thoracicthe UICC TNM classification.2 Patient characteristics are shown in
Table 1.
Histopathologic studies were done according to the World
Health Organization criteria,5 and VPI was reviewed in detail.
Tumor sections were stained with hematoxylin and eosin and
Victoria-blue van Gieson stains. VPI was classified according to
the JLCS criteria3: p0; tumor with no pleural involvement beyond
its elastic layer; p1, tumor that extends beyond the elastic layer of
the visceral pleura but is not exposed on the pleural surface (Figure
1, A); and p2, tumor that is exposed on the pleural surface but does
not involve adjacent anatomic structures (Figure 1, B). All patients
were divided into 7 groups, A to G, according to the tumor
diameter (3 cm or 3 cm), VPI (p0, p1, or p2), and T3 factor,
as shown in Table 2.
We analyzed the overall survival of patient groups A to G. We
also evaluated survival of patients without lymph node involve-
ment (n0) in each group. Survival was estimated by using the
Kaplan-Meier method,6 and differences in survival were deter-
mined by means of log-rank analysis.7 Zero time was the date of
pulmonary resection, and the terminal event was defined as any
death.
Results
Patient Characteristics and VPI
Table 1 shows the patient characteristics. There were 568
women and 1085 men aged 30 to 89 years (mean, 63 years;
median, 65 years). Extents of pulmonary resection were
No. of patients (%)
p2 T3 Total
9 63 10 63 10 63 10
9 35-85 34-83 30-89
4 34/47 212/34 1085/568
) 0 (0) 3 (1) 29 (2)
4) 79 (98) 186 (76) 1512 (91)
) 2 (3) 57 (23) 112 (7)
0) 70 (87) 85 (35) 997 (60)
8) 9 (11) 118 (48) 513 (31)
) 2 (3) 21 (9) 79 (5)
) 0 (0) 22 (9) 42 (4)
0) 33 (41) 38 (15) 802 (49)
0) 48 (59) 208 (85) 851 (51)
0) 44 (54) 110 (45) 1112 (67)
7) 9 (11) 62 (25) 251 (15)
3) 28 (35) 74 (30) 290 (18)
81 246 1653
is; n1, metastasis to ipsilateral peribronchial hilar lymph nodes, ipsilateral
by direct extension of the primary tumor; n2, metastasis to ipsilateralp1
66
42-8
177/9
5 (2
54 (9
12 (4
63 (6
75 (2
20 (7
13 (5
07 (4
64 (6
63 (6
46 (1
62 (2
271
tastas
mentpneumonectomy (n  112), lobectomy (n  1512), and
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cinoma (n  997), squamous cell carcinoma (n  513),
large cell carcinoma (n  79), and adenosquamous carci-
noma (n  64).
Survival Difference
The overall 5-year survivals for groups A through G were
79%, 63%, 42%, 60%, 39%, 35%, and 36%, respectively
(Figures 2 and 3). The difference in survival between groups
A and B, between groups A and C, between groups B and
G, and between groups C and G (Figure 2) and the differ-
Figure 1. A, Tumor cells extend beyond the visceral pleural
elastic layer (arrowheads) but are not exposed on the pleural
surface: p1. B, Tumor cells extend beyond the visceral pleural
elastic layer (arrowheads) and are exposed on the pleural sur-
face but do not involve the parietal pleura: p2.ence in survival between groups D and E and between
1576 The Journal of Thoracic and Cardiovascular Surgery ● Jungroups D and F (Figure 3) were significant. In contrast, the
survival curves for groups B and D almost overlapped with
each other, and there was no statistically significant differ-
ence in survival between the groups (Figure 2). Similarly,
there was no statistically significant difference in survival
between groups C and D and between groups B and C
(Figure 2), nor was there a significant difference in survival
between groups E and F (Figure 3). Also, the differences in
survival between groups E and G and between groups F and
G were not significant (Figure 3). Outcomes were also
examined in the n0 patient cohort, and similar relationships
were observed.
Discussion
The JLCS classifies VPI into 4 groups (p0, p1, p2, and p3),
whereas in the UICC classification p1 and p2 involvements
are not distinguished. If p1 pleural involvement is inter-
preted as VPI in the UICC classification, there appears to be
inconsistency in the T1/T2 definition between the UICC and
JLCS TNM classification.
Brewer and colleagues,1 Ichinose and coworkers,8 and
Manac’h and associates9 demonstrated that pleural invasion
is an important poor prognosis factor. In their reports,
however, p1 and p2 invasions were combined and analyzed
as a single VPI category. In our study we conducted uniform
hematoxylin and eosin and Victoria-blue van Gieson stain-
ing on all tumors and performed histologic review in all
cases, with special interest in VPI and its JLCS subclassi-
fications, p0, p1, and p2. We retrospectively analyzed post-
operative survival in patients with p0, p1, p2, or T3 cancer
to evaluate the significance of pleural involvement extent as
a prognostic factor.
In our series the 5-year survivals for the patients with p1
or p2 tumors of 3 cm or less were identical and significantly
TABLE 2. Seven groups according to tumor diameter, VPI,
and T3 factor
Group
Tumor size
diameter VPI p-factor*
All patients,
n (%)
Patients with
n0 disease,
n (%)
A 3cm p0 624 (38) 507 (46)
B 3cm p1 107 (7) 79 (7)
C 3cm p2 33 (2) 23 (2)
D 3cm p0 431 (26) 288 (26)
E 3cm p1 164 (10) 84 (8)
F 3cm p2 48 (3) 21 (2)
G Patients with T3 tumors
as defined by the UICC
TNM classification
246 (15) 110 (10)
VPI, Visceral pleural invasion; UICC, International Union Against Cancer.
*The Japan Lung Cancer Society classification of visceral pleura invasion.worse than those for patients with p0 disease with the same
e 2004
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TSFigure 2. Survival curves and overall 5-year survivals for groups A, B, C, D, and G. The differences in survival
between groups A and B, between groups A and C (P < .01), between groups B and G (P < .01), between groups
C and G (P  .04), and between groups D and G were significant. There was no statistically significant difference
in survival between groups B and C, between groups B and D (P  .38), and between groups C and D.Figure 3. Survival curves and overall 5-year survivals for groups D, E, F, and G. The differences in survival between
groups D and E, between groups D and F (P < .01), and between groups D and G (P < .01) were significant. There
was no statistically significant difference in survival between groups E and F, between groups E and G (P  .38),
and between groups F and G.
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p1 or p2 tumors greater than 3 cm were identical, whereas
they were notably worse than those in patients with p0
disease with the same size cancers. Furthermore, there was
no statistically significant difference in survival between the
patients with p1 or p2 tumors greater than 3 cm and the
patients with T3 cancers. Similar relationships were ob-
served among patients with n0 disease.
These results indicate that p1 and p2 pleural involvement
should be combined as a single category as VPI. A tumor of
3 cm or less with p1 involvement should, unlike the JLCS
classification, be classified as T2. Although the UICC clas-
sifies a tumor of greater than 3 cm as T2 regardless of
pleural involvement, our results suggest p1 or p2 tumors of
greater than 3 cm should be upgraded to T3 status (Table 3).
In conclusion, this study indicates that VPI should be
defined as tumor extension beyond the elastic layer of the
visceral pleura, regardless of its exposure on the pleural
surface. A tumor of 3 cm or less with VPI should remain a
T2 tumor, as presently occurs in the UICC staging system
(but upgraded in the JLCS staging system to match the
UICC system), and tumors of greater than 3 cm with VPI
should be upgraded to T3 status in both staging systems.
This modification would make the non–small cell lung
cancer TNM classification system simpler and cleaner.
TABLE 3. Difference between the UICC, the JLCS, and our
Classification
<3 cm
without VPI w
UICC T1
JLCS T1 (p0*) T1 (p
Ours T1
UICC, International Union Against Cancer; JLCS, Japan Lung Cancer Soc
*The Japan Lung Cancer Society classification of visceral pleura invasion1578 The Journal of Thoracic and Cardiovascular Surgery ● JunWe thank Professor J. Patrick Barron (International Medical
Communication Center, Tokyo Medical University) for reviewing
the English manuscript.
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